|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
Chest, Vol 75, 85-86, Copyright © 1979 by American College of Chest Physicians
ARTICLES |
RB Prior, VA Spagna and RL Perkins
Endocarditis caused by Cardiobacterium hominis was observed in a penicillin-allergic patient with a prosthetic cardiac valve who had received prophylactic therapy with erythromycin for dental extractions. The organism was resistant to erythromycin and vancomycin, with minimal inhibitory concentrations of 12.5 microgram/ml and 25 microgram/ml, respectively, but was sensitive to penicillin G, tetracycline, cephalexin, and cefaclor. This case suggests that currently recommended antibiotic prophylactic therapy for endocarditis, especially in penicillin-allergic patients, may be inadequate for unusual pathogens such as C hominis.
This article has been cited by other articles:
![]() |
P.-L. Lu, P.-R. Hsueh, C.-C. Hung, L.-J. Teng, T.-N. Jang, and K.-T. Luh Infective Endocarditis Complicated with Progressive Heart Failure due to beta -Lactamase-Producing Cardiobacterium hominis J. Clin. Microbiol., May 1, 2000; 38(5): 2015 - 2017. [Abstract] [Full Text] |
||||
![]() |
P F Currie, M Codispoti, P S Mankad, and M J Godman Late aortic homograft valve endocarditis caused by Cardiobacterium hominis: a case report and review of the literature Heart, May 1, 2000; 83(5): 579 - 581. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |